HighTower Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

HighTower Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-39,372	Closed	-$1.39M	–	1827
2015 Q1	$1.39M	Buy	39,372 +903	+2%	+$30.6K	0.02%	700
2014 Q4	$1.24M	Sell	38,469 -37,434	-49%	-$1.08M	0.02%	730
2014 Q3	$2.13M	Buy	75,903 +1,540	+2%	+$46.9K	0.04%	531
2014 Q2	$2.25M	Buy	74,363 +894	+1%	+$24.7K	0.04%	531
2014 Q1	$2.03M	Buy	73,469 +19,782	+37%	+$518K	0.04%	509
2013 Q4	$1.37M	Sell	53,687 -60,976	-53%	-$1.88M	0.03%	601
2013 Q3	$3.43M	Buy	114,663 +76,251	+199%	+$2.12M	0.09%	261
2013 Q2	$1.1M	Buy	+38,412	New	+$1.06M	0.03%	568

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

HighTower Advisors's BRLI Position: Q2 2015 in Review

HighTower Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 39,372 shares — an estimated $1.39M sold.

HighTower Advisors first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $3.43M in Q3 2013. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

HighTower Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
HighTower Advisors sold 39,372 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $1.39M.
HighTower Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
HighTower Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $3.43M in Q3 2013.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on HighTower Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.